Libby's H*O*P*E*

*Helping*Ovarian Cancer Survivors*Persevere Through*Education

Menu

Skip to content
  • Home
  • About
  • Mission
  • Warning Signs & Symptoms
  • Ovarian Cancer Overview
  • Prevention, Early Detection/Screening & Causes
  • Genetics
  • Types of Ovarian Cancer
  • Diagnosis & Staging
  • Treatment Overview
  • Surgery
  • Chemotherapy
  • Radiology & Radiation Therapy
  • Hormonal (Anti-Estrogen) Therapy
  • Biological (Immunotherapy & Vaccine) Therapy
  • Gene Therapy
  • Alternative & Complementary Therapy
  • Clinical Development
  • Clinical Trials
  • Coping
  • Survivorship
  • Ovarian Cancer Resources
  • Contact

Contact






Share this:

  • Facebook
  • Twitter
  • Google
  • Pinterest
  • LinkedIn
  • Tumblr
  • Reddit
  • Pocket
  • Print
  • Email

Like this:

Like Loading...
"Once you choose hope, anything is possible." -- Christopher Reeve

Categories

Twitter Updates

My Tweets

RSS Google Ovarian Cancer News

  • Artificial intelligence can predict survival of ovarian cancer patients - Medical Xpress February 15, 2019
  • A Patient's Guide to Ovarian Cancer - U.S. News & World Report February 15, 2019
  • New Agents Push the Envelope in Ovarian Cancer - OncLive February 10, 2019
  • Targeting Ovarian Cancer - Curetoday.com February 2, 2019
  • Global Ovarian Cancer Drugs Market Outlook, 2019-2023 with AstraZeneca, Clovis Oncology, F. Hoffmann-La Roche, Spectrum Pharmaceuticals, and Tesaro Dominating - ResearchAndMarkets.com - Business Wire February 13, 2019
  • Surgeon Discusses Frontline Standard in Newly Diagnosed Ovarian Cancer - OncLive January 16, 2019
  • Matulonis Highlights Novel Strategies, Emerging Agents in Ovarian Cancer - OncLive January 25, 2019
  • Brisbane woman in world first for ovarian cancer treatment - Courier Mail February 15, 2019
  • Novel Genetic Marker in Ovarian, Lung Cancers - Cancer Network February 12, 2019
  • Expert Focuses on Facets of Genetic Testing in Ovarian Cancer - OncLive January 31, 2019
  • Ovarian cancer: Is it possible after a hysterectomy? - Medical News Today January 21, 2019
  • Studies Seek to Expand on PARP Inhibitor Success in Ovarian Cancer - OncLive January 29, 2019
  • Immunotherapy Combos May Have Role in Ovarian Cancer - OncLive January 23, 2019
  • Adjuvant GI-Based Chemo Regimens Improve Survival in Mucinous Ovarian Cancer - OncLive January 18, 2019
  • PARP Combos May Represent Future in Frontline Maintenance Ovarian Cancer Setting - OncLive January 17, 2019
  • Antiangiogenics, ADCs Still Have Roles in Ovarian Cancer Treatment - OncLive January 20, 2019
  • First-line treatment of women with advanced ovarian cancer: focus on b | OTT - Dove Medical Press February 7, 2019
  • Dr. Karam on the Use of Laparoscopy in Advanced Ovarian Cancer - OncLive February 8, 2019
  • 'General Hospital' Spoilers: Carly Pregnant or Ovarian Cancer February Sweeps Storyline? - Soap Dirt February 14, 2019
  • European Commission Approves Maintenance Rucaparib in Ovarian Cancer - OncLive January 24, 2019

Top Posts

  • About
    About
  • Contact
    Contact
  • A Way to Kill Chemo-Resistant Ovarian Cancer Cells: Cut Down Their Protector
    A Way to Kill Chemo-Resistant Ovarian Cancer Cells: Cut Down Their Protector
  • The Mirror: "What is the Meaning of Life?"
    The Mirror: "What is the Meaning of Life?"
  • Ovarian Cancer Resources
    Ovarian Cancer Resources
  • 2011 ASCO: Exelixis Reports Expanded Cabozantinib (XL184) Phase II Data For Advanced Ovarian Cancer; Six Deaths Reported
    2011 ASCO: Exelixis Reports Expanded Cabozantinib (XL184) Phase II Data For Advanced Ovarian Cancer; Six Deaths Reported
  • Ovarian Cancer Tumors Can Grow For Ten Years Or More Before Being Detected By Today's Blood Tests
    Ovarian Cancer Tumors Can Grow For Ten Years Or More Before Being Detected By Today's Blood Tests
  • OVA1 Blood Test Detects Ovarian Cancer In Women With A Known Ovarian Mass More Accurately Than CA-125
    OVA1 Blood Test Detects Ovarian Cancer In Women With A Known Ovarian Mass More Accurately Than CA-125
  • 2011 SGO Annual Meeting: Ovarian Cancer Abstracts Selected For Presentation
    2011 SGO Annual Meeting: Ovarian Cancer Abstracts Selected For Presentation
  • Caris Life Sciences Launches Molecular Profiling Service For Ovarian Cancer Patients
    Caris Life Sciences Launches Molecular Profiling Service For Ovarian Cancer Patients

Archives

  • May 2015
  • September 2014
  • August 2014
  • May 2014
  • March 2014
  • August 2013
  • May 2013
  • February 2013
  • January 2013
  • July 2012
  • June 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008

Blog Stats

  • 486,792 Visitors
cancer blog

Enter your email address to subscribe to Libby's H*O*P*E* & receive notifications of new posts by email.

Join 2,115 other followers

 Subscribe in a reader

Click on the orange button above if you want to (i) add Libby's H*O*P*E*(tm) updates to a web-based or other reader, or (ii) embed a Libby's H*O*P*E* (tm) update widget on your desktop, website or blog.

Donate To Ovarian Cancer Research

OCRF is the largest U.S. private funding agency supporting ovarian cancer research. It is a not-for-profit, 501(c)(3) organization. Click on the OCRF logo above to make a donation.

Strategic Partners

Podcasts

Join Us In the Fight Against Ovarian Cancer

RSS New Ovarian Cancer Clinical Trials (Past 14 Days)

  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI) February 15, 2019
  • A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. February 15, 2019
  • Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors February 4, 2019
  • A Trial Evaluating TG4050 in Ovarian Carcinoma. February 15, 2019
  • Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies February 7, 2019
  • Pediatric Reporting of Adult-Onset Genomic Results February 6, 2019
  • A Study of pING-hHER3FL Vaccine in Cancer Patients With Advanced Malignancies February 6, 2019
  • Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors February 11, 2019

RSS New Adult Solid Tumor Clinical Trials (Past 14 Days)

  • Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations February 15, 2019
  • Phase I Clinical Study of MBS301 in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor February 15, 2019
  • A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) February 7, 2019
  • Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) February 7, 2019
  • A Safety Study of NUC-7738 in Patients With Advanced Solid Tumours or Lymphoma February 4, 2019
  • Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001) February 7, 2019
  • FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors February 15, 2019
  • A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies February 8, 2019
  • Durvalumab and Tremelimumab for Pediatric Malignancies February 12, 2019
  • Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia February 8, 2019

RSS Medical Studies

  • Assessment of the diagnostic value of using serum CA125 and GI-RADS system in the evaluation of adnexal masses.
  • Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance.
  • Does lymphadenectomy effect postoperative surgical morbidity and survival in patients with adult granulosa cell tumor of ovary?
  • High Ki-67 expression is significantly associated with poor prognosis of ovarian cancer patients: evidence from a meta-analysis.
  • CCL20 Promotes Ovarian Cancer Chemotherapy Resistance by Regulating ABCB1 Expression.
  • Microvesicle Proteomic profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.
  • Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
  • TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers.
  • Low glucose and metformin-induced apoptosis of human ovarian cancer cells is connected to ASK1 via mitochondrial and endoplasmic reticulum stress-associated pathways.

Recent Comments

Paul Cacciatore on About
Building a Team for… on About
Kathleen on About
Paul Cacciatore on About
Liz on About
Paul Cacciatore on Dana Farber Webchat: The Lates…
Judith Marengere on Dana Farber Webchat: The Lates…
Paul Cacciatore on Dana Farber Webchat: The Lates…
Franca Pichini on Dana Farber Webchat: The Lates…
painspeaks on SU2C Announces the Formation o…
marcy westerling on SU2C Announces the Formation o…
anne on Dana-Farber Oncologists Differ…
Personalized Medicin… on 2011 ASCO: Matching Targeted T…
YoTrip Presents: Sep… on U.S. President Barack Obama Pr…
Paul Cacciatore on U.S. President Barack Obama Pr…

Blogroll

  • Site Meter Site Meter

Cancer Organizations

  • American Cancer Society
  • National Cancer Institute

Everyday Heroes

  • Are You There Cancer? It's Me, Jennie.
  • Bald Heads Are Sexy
  • Butterfly Ballet
  • Cancer Queen
  • Carrie's Journey
  • Chris Bledy
  • Diary of a Cancer Patient
  • I Want To Breathe
  • Janine's News
  • Journey Through Ovarian Cancer
  • Kristi & Brian: Living! With Cancer
  • Laurey Bikes
  • Life Cycle
  • livingly dying
  • Marcheline Bertrand Remembered
  • Meghan's Message
  • Monday Hearts For Madalene
  • My Journey With Teal
  • Nobody Has Ovarian Cancer
  • Out Shine Ovarian Cancer
  • OVACOM
  • Ovarian Cancer News
  • Ovarian Cancer?? pass the wine … now!
  • Scrambled Eggs, Surviving Ovarian Cancer
  • Shannon Miller Lifestyle
  • Still Smiling
  • Strong As Steele
  • Tenaciously Teal
  • The Carcinista
  • What? Me Worry?
  • Will There Be Cows In Heaven?
  • Women of Teal

Inspirational Cancer Advocates

  • Bald Is Beautiful
  • Bicycling For Ovarian Cancer (Craig Broeder)
  • Christine Druther
  • Fran Drescher
  • Imerman Angels
  • Jenn Sommermann: Training For a Cure
  • Jim Valvano
  • Laurey Masterton
  • Maddie Kullen
  • Mothers With Cancer
  • Randy Pausch
  • Sean Swarner
  • Standup2cancer
  • The Rock Band N.E.D.

Ovarian Cancer News Archive

  • Ovarian Cancer News Archive

Ovarian Cancer Organizations

  • National Breast & Ovarian Cancer Connection
  • National Ovarian Cancer Coalition
  • Ovarian Cancer National Alliance
  • Ovarian Cancer Research Fund
  • Ovations For the Cure

U.S. Treatment Centers

  • National Comprehensive Cancer Network Member Institutions
  • NCI-Designated Cancer Centers

Video Archive

  • Ovarian Cancer Video Library
Copyright 2008 - 2016 Paul Cacciatore, Libby's H*O*P*E*(TM), *Helping *Ovarian Cancer Survivors *Persevere Through *Education(TM), all rights reserved.
Paul Cacciatore

Create Your Badge
Site Meter
Blog at WordPress.com.
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: